[go: up one dir, main page]

CA2258601A1 - Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier - Google Patents

Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier

Info

Publication number
CA2258601A1
CA2258601A1 CA002258601A CA2258601A CA2258601A1 CA 2258601 A1 CA2258601 A1 CA 2258601A1 CA 002258601 A CA002258601 A CA 002258601A CA 2258601 A CA2258601 A CA 2258601A CA 2258601 A1 CA2258601 A1 CA 2258601A1
Authority
CA
Canada
Prior art keywords
cartilage
bone
matrix
defect
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002258601A
Other languages
French (fr)
Other versions
CA2258601C (en
Inventor
Ernst B. Hunziker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/672,618 external-priority patent/US5853746A/en
Application filed by Individual filed Critical Individual
Publication of CA2258601A1 publication Critical patent/CA2258601A1/en
Application granted granted Critical
Publication of CA2258601C publication Critical patent/CA2258601C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods and compositions are provided for the treatment and repair of defects in the cartilage or bone of humans and other animals as in full-thickness defects in joints. To induce cartilage formation, a defect in cartilage is filled with a matrix having pores sufficiently large to allow cartilage repair cells to populate the matrix. The matrix contains an anti-angiogenic agent that serves as a functional barrier to prevent vascularization and bone growth into the cartilage area. The matrix filling the defect in cartilage may also contain a proliferation agent and a chemotactic agent, and a transforming factor in an appropriate delivery system. A functional barrier between the bone and cartilage areas of a full-thickness defect may also be created by heat-treating the areas of bleeding to form a transient tissue barrier which prevents blood vessels and associated cells from penetrating from the bone area into the cartilage area. If desired, the bone portion of the full-thickness defect may be filled with a matrix having pores large enough to allow cells to populate the matrix and to form blood vessels.
The matrix filling the bone defect may contain an angiogenic factor and an osteogenic factor in an appropriate delivery system. Methods and compositions are also provided for assisted bone and connective tissue regeneration for dental and other applications.
CA002258601A 1996-06-28 1997-06-24 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier Expired - Fee Related CA2258601C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/672,618 US5853746A (en) 1991-01-31 1996-06-28 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US08/672,618 1996-06-28
PCT/US1997/011208 WO1998000183A2 (en) 1996-06-28 1997-06-24 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier

Publications (2)

Publication Number Publication Date
CA2258601A1 true CA2258601A1 (en) 1998-01-08
CA2258601C CA2258601C (en) 2007-04-10

Family

ID=38007254

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002258601A Expired - Fee Related CA2258601C (en) 1996-06-28 1997-06-24 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier

Country Status (1)

Country Link
CA (1) CA2258601C (en)

Also Published As

Publication number Publication date
CA2258601C (en) 2007-04-10

Similar Documents

Publication Publication Date Title
WO1998000183A3 (en) Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
CA2116859A1 (en) Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
ZA92726B (en) Methods and compositions for the treatment and repair of defects or lesions in cartilage
DE69918717T2 (en) BONE TRANSPLANT FROM BONE PARTICLES
EP2514445A3 (en) Bioactive hydrogel compositions
Shapoff et al. The effect of particle size on the osteogenic activity of composite grafts of allogeneic freeze‐dried bone and autogenous marrow
JP2002531193A (en) Methods and articles for regenerating living tissue
RU94030735A (en) COMPOSITION MEMBRANE, METHOD FOR ITS PREPARATION AND METHOD FOR DIRECTED TISSUE REGENERATION WITH ITS APPLICATION
ATE541594T1 (en) METHODS AND COMPOSITIONS FOR HEALING AND REPAIRING ARTicular cartilage
NZ334400A (en) Method, instruments and kit for autologous transplantation comprising hemostatic barrier and a covering patch
CA2179017A1 (en) Peracetic acid sterilization
WO1998022154A3 (en) Biopolymer foams for use in tissue repair and reconstruction
CA2018448A1 (en) Injectable polymeric bodies
Ishikawa et al. Dentin materials as biological scaffolds for tissue engineering
Luczyszyn et al. Histologic analysis of the acellular dermal matrix graft incorporation process: a pilot study in dogs.
PT1148897E (en) METHODS AND COMPOSITIONS FOR HEALING AND REPAIR OF JOINT CARTILAGE
CA2258601A1 (en) Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
Guarnieri et al. Histologic evaluation of bone healing of adjacent alveolar sockets grafted with bovine-and porcine-derived bone: a comparative case report in humans
Lewandrowski et al. Augmentation of osteoinduction with a biodegradable poly (propylene glycol‐co‐fumaric acid) bone graft extender: A histologic and histomorphometric study in rats
Hile et al. An injectable porous poly (propylene glycol‐co‐fumaric acid) bone repair material as an adjunct for intramedullary fixation
Vachon Repair of osteochondral defects of the equine radial carpal bone with glued periosteal autografts.
Cui et al. Experimental studies on bone defect reconstruction of dog radius using injectable osteoinductive material with fibrin sealant as vehicles
EP0792878A3 (en) Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
Son The Current Status of Periodontal Treatment in Korea
BR9905465A (en) Method of preparing lignocellulosic materials for macroscopic analysis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed